Axsome AUVELITY wins FDA approval for Alzheimer's agitation treatment

May 1, 2026 7:15 AM

Axsome Therapeutics Inc. (NASDAQ: AXSM) announced that the U.S. Food and Drug Administration approved AUVELITY for treating agitation associated with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found